- Home
- LFMD vs BBNX Comparison
LFMD vs BBNX Comparison
Compare LFMD & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- BBNX
- Stock Information
- Founded
- LFMD 1994
- BBNX 2015
- Country
- LFMD United States
- BBNX United States
- Employees
- LFMD N/A
- BBNX N/A
- Industry
- LFMD Medical/Nursing Services
- BBNX Medical/Dental Instruments
- Sector
- LFMD Health Care
- BBNX Health Care
- Exchange
- LFMD Nasdaq
- BBNX Nasdaq
- Market Cap
- LFMD 535.4M
- BBNX 578.8M
- IPO Year
- LFMD N/A
- BBNX 2025
- Fundamental
- Price
- LFMD $10.55
- BBNX $13.79
- Analyst Decision
- LFMD Buy
- BBNX Strong Buy
- Analyst Count
- LFMD 6
- BBNX 10
- Target Price
- LFMD $12.50
- BBNX $25.20
- AVG Volume (30 Days)
- LFMD 1.6M
- BBNX 470.7K
- Earning Date
- LFMD 08-06-2025
- BBNX 07-29-2025
- Dividend Yield
- LFMD N/A
- BBNX N/A
- EPS Growth
- LFMD N/A
- BBNX N/A
- EPS
- LFMD N/A
- BBNX N/A
- Revenue
- LFMD $234,007,330.00
- BBNX $69,830,000.00
- Revenue This Year
- LFMD $29.80
- BBNX $32.71
- Revenue Next Year
- LFMD $18.03
- BBNX $37.37
- P/E Ratio
- LFMD N/A
- BBNX N/A
- Revenue Growth
- LFMD 43.07
- BBNX 38911.17
- 52 Week Low
- LFMD $3.99
- BBNX $8.89
- 52 Week High
- LFMD $15.84
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- LFMD 35.90
- BBNX N/A
- Support Level
- LFMD $10.68
- BBNX N/A
- Resistance Level
- LFMD $11.47
- BBNX N/A
- Average True Range (ATR)
- LFMD 0.64
- BBNX 0.00
- MACD
- LFMD -0.32
- BBNX 0.00
- Stochastic Oscillator
- LFMD 0.00
- BBNX 0.00
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.